Iswar K. Hariharan
- Cell Biology top 0.1%
- Hippo pathway signaling and YAP/TAZ 31
- Aging top 0.5%
- Molecular Biology top 1%
- Developmental Biology and Gene Regulation 21
- Ubiquitin and proteasome pathways 10
- Wnt/β-catenin signaling in development and cancer 7
- CRISPR and Genetic Engineering 6
-
- Neurobiology and Insect Physiology Research 14
- Hematology top 2%
-
- Cancer-related Molecular Pathways 8
-
- Invertebrate Immune Response Mechanisms 7
- Co-authors
- Kieran F. HarveyCathie M. PflegerNicolas TaponDaniel A. HaberKenneth H. MobergDoke C.R. WahrerDaphne W. BellSuzanne Cory
- Cited by
- Cell BiologyAgingMolecular Biology
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Iswar K. Hariharan
74 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Cell Biology 3.3k
- Aging 309
- Molecular Biology 4.7k
- Cellular and Molecular Neuroscience 1.1k
- Hematology 498
Countries citing papers authored by Iswar K. Hariharan
This map shows the geographic impact of Iswar K. Hariharan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iswar K. Hariharan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iswar K. Hariharan more than expected).
Fields of papers citing papers by Iswar K. Hariharan
This network shows the impact of papers produced by Iswar K. Hariharan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iswar K. Hariharan. The network helps show where Iswar K. Hariharan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Iswar K. Hariharan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 15 | |
| 2 | 2021 | 30 | |
| 3 | 2018 | 33 | |
| 4 | 2017 | 51 | |
| 5 | 2016 | 18 | |
| 6 | 2012 | 56 | |
| 7 | 2010 | 135 | |
| 8 | 2007 | 76 | |
| 9 | 2006 | 29 | |
| 10 | 2006 | 85 | |
| 11 | 2005 | 1 | |
| 12 | 2005 | 4 | |
| 13 | 2004 | 110 | |
| 14 | The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosisbreakdown → | 2003 | 812 |
| 15 | salvador Promotes Both Cell Cycle Exit and Apoptosis in Drosophila and Is Mutated in Human Cancer Cell Linesbreakdown → | 2002 | 723 |
| 16 | 2002 | 9 | |
| 17 | 2001 | 63 | |
| 18 | 2001 | 440 | |
| 19 | 2000 | 51 | |
| 20 | 1993 | 59 |
About Iswar K. Hariharan
Iswar K. Hariharan is a scholar working on Cell Biology, Aging and Cellular and Molecular Neuroscience, having authored 75 papers that have together received 7.1k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (31 papers), Developmental Biology and Gene Regulation (21 papers), Neurobiology and Insect Physiology Research (14 papers), Ubiquitin and proteasome pathways (10 papers), Cancer-related Molecular Pathways (8 papers), Invertebrate Immune Response Mechanisms (7 papers), Wnt/β-catenin signaling in development and cancer (7 papers) and CRISPR and Genetic Engineering (6 papers). The work is most often cited by research in Cell Biology (3.3k citations), Aging (309 citations) and Molecular Biology (4.7k citations). Iswar K. Hariharan has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Kieran F. Harvey, Cathie M. Pfleger, Nicolas Tapon, Daniel A. Haber, Kenneth H. Moberg, Doke C.R. Wahrer, Daphne W. Bell, Suzanne Cory, Melanie I. Worley and Taryn A. Schiripo. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.